Reliability and validity of a brief self-rated scale of health condition with acute schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 68, Issue 1, 2014, Pages 70-77

  Ohata, Hisanori ^a,b   Yotsumoto, Kayano ^a   Taira, Masaru ^b,c   Kochi, Yoshiro ^b   Hashimoto, Takeshi ^a  

^a KOBE UNIVERSITY   (Japan)

^b Hyogo Prefectural Amagasaki Hospital   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

health; reliability; schizophrenia; self rating scale; validity

Indexed keywords

CHLORPROMAZINE;

ACUTE DISEASE; BRIEF PSYCHIATRIC RATING SCALE; BRIEF SCALE OF SELF RATED HEALTH CONDITION WITH ACUTE SCHIZOPHRENIA; COMPARATIVE STUDY; CONTENT VALIDITY; EFFECT SIZE; FATIGUE; FEMALE; HOSPITAL PATIENT; HUMAN; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD; PSYCHOLOGIC ASSESSMENT; RATING SCALE; REVIEW; SCHIZOPHRENIA; TEST RETEST RELIABILITY; ADULT; AFFECT; COMPLICATION; FORENSIC PSYCHIATRY; HEALTH STATUS; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REPRODUCIBILITY; SELF REPORT; STANDARDS; STATISTICAL MODEL; SYMPTOM ASSESSMENT; VALIDATION STUDY;

ADULT; AFFECT; COMMITMENT OF MENTALLY ILL; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; MALE; MODELS, STATISTICAL; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF REPORT; SYMPTOM ASSESSMENT;

EID: 84891829222     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12105     Document Type: Review

References (22)

1. Ito H,. Quality and performance improvement for mental healthcare in Japan. Curr. Opin. Psychiatry 2009; 22: 619-622.
2. Oshima I, Mino Y, Inomata Y,. Institutionalization and schizophrenia in Japan: Social environments and negative symptoms: Nationwide survey of in-patients. Br. J. Psychiatry 2003; 183: 50-56.
3. McCabe R, Saidi M, Priebe S,. Patient-reported outcomes in schizophrenia. Br. J. Psychiatry 2007; 191 (Suppl 50): S21-S28.
4. Hamann J, Leucht S, Kissling W,. Shared decision making in psychiatry. Acta Psychiatr. Scand. 2003; 107: 403-409.
5. Hamann J, Langer B, Winkler V, et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatr. Scand. 2006; 114: 265-273.
6. Takamatsu T, Hashimoto T, Taira M, Fukutake M, Maeda K,. Scale for measuring self-recoverability in daily life for people with schizophrenia. Psychiatry Clin. Neurosci. 2009; 63: 277-282.
7. Taira M, Hashimoto T, Takamatsu T, Maeda K,. Subjective response to neuroleptics: The effect of a questionnaire about neuroleptic side effects. Prog. Neuropsychopharmacol Biol. Psychiatry 2006; 30: 1139-1142.
8. Fleischhacker WW, Rabinowitz J, Kemmler G, Eerdekens M, Mehnert A,. Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. Br. J. Psychiatry 2005; 187: 131-136.
9. Russo J, Trujillo CA, Wingerson D, et al. The MOS 36-Item Short Form Health Survey: Reliability, validity, and preliminary findings in schizophrenic outpatients. Med. Care 1998; 36: 752-756.
10. Lehman AF, Fischer EP, Postrado L, et al. The Schizophrenia Care and Assessment Program Health Questionnaire (SCAP-HQ): An instrument to assess outcomes of schizophrenia care. Schizophr. Bull. 2003; 29: 247-256.
11. Naber D, Moritz S, Lambert M, et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr. Res. 2001; 50: 79-88.
12. Kobayashi M, Tomioka N, Fukushima S,. Developing of inventory scale of daily activities for sub-acute in-patients (ISDA) and inventory scale for mood and sense of fatigue (SMSF). Jpn. J. Psychiatr. Rehabil. 2006; 10: 18-19 (in Japanese).
13. Dickey B,. Outcomes Assessment in Clinical Practice. Lippincott Williams & Wilkins, Baltimore, 1996.
14. Bartko JJ,. On various intraclass correlation reliability coefficients. Psychol. Bull. 1976; 83: 762-765.
15. Organization WH,. International Classification of Diseases and Related Health Problems-10th Revision. World Health Organization, Geneva, 2004.
16. Fayers PM, Machin D,. Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. John Wiley & Sons, Chichester, 2007.
17. Cohen J,. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum, Hillsdale, 1988.
18. Overall J, Gorham D,. The brief psychiatric rating-scale. Psychol. Rep. 1962; 10: 799-812.
19. Overall JE, Hollister LE, Pichot P,. Major psychiatric disorders. A four-dimensional model. Arch. Gen. Psychiatry 1967; 16: 146-151.
20. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15: 141-155.
21. Nakai H, Yamaguchi N,. Kango no tame no seishin igaku [Psychiatry for Nursing]. Igaku Shoin, Tokyo, 2001 (in Japanese).
22. Tunis SL, Croghan TW, Heilman DK, Johnstone BM, Obenchain RL,. Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Med. Care 1999; 37: 678-691.